Go to deals
Healthcare

Medartis has acquired the remaining stake in KeriMedical and completed a PPA

July 2025 — Medartis Holding AG has acquired the remaining stake in KeriMedical S.A., gaining full access to an innovative hand portfolio, strengthening its technological expertise in joint replacement and broadening its global surgeon network. Following the transaction, a purchase price allocation (PPA) in accordance with IFRS 3 was prepared for accounting purposes.

Headquartered in Basel, Switzerland, Medartis is a leading global manufacturer and provider of medical devices for the surgical fixation of bone fractures of the upper and lower extremities as well as the craniomaxillofacial region. The company was founded in 1997 and employs approximately 1,200 people across 13 locations, with products sold in over 50 countries worldwide. Medartis is committed to providing surgeons and operating theater personnel with innovative titanium implants and instruments, complemented by best-in-class service.

Founded in 2016, KeriMedical specializes in the development and commercialization of a comprehensive range of implants exclusively for hand and wrist surgery. The company’s team has extensive experience in orthopedic surgery with expertise across all operational areas, including design, manufacturing, quality, marketing and product promotion. It collaborates closely with a panel of internationally recognized surgeons. KeriMedical is headquartered in Geneva, employs approximately 150 people and its products are available in 30 countries.

Our role in the transaction

Oaklins’ team in Switzerland supported Medartis in the post-transaction phase by preparing a PPA in accordance with IFRS 3. The report included the allocation of the purchase price to identifiable acquired assets, assumed liabilities and goodwill.

“We would like to express our thanks to the Oaklins team for their efficient and professional preparation of the PPA. We benefited from Oaklins’ experience and professionalism throughout the entire process.”

Reto Schmitt

Head of technical finance and external reporting, Medartis Holding AG

Talk to the deal team

Dr. Daniel Spring

Partner
Bern, Switzerland
Oaklins Switzerland

Yannick Bischoff

Senior Associate
Bern, Switzerland
Oaklins Switzerland

Related deals

itemedical has been acquired by Halma
Healthcare | TMT

itemedical has been acquired by Halma

itemedical, a Netherlands-based provider of digital platforms that integrate real-time patient data and alarms from a wide range of medical devices to support clinical decision-making and workflow efficiency in hospitals, has been acquired by Halma plc, a global group of life-saving technology companies. The acquisition represents a milestone in itemedical’s development and provides a platform for its next phase of growth. By joining Halma’s healthcare sector as a business unit of Halma subsidiary Static Systems Group (SSG), itemedical will strengthen its position as a provider of digital hospital workflow solutions, benefiting from access to a global network of technology businesses, resources to accelerate innovation and opportunities to expand its international footprint.

Learn more
Indigo Capital has acquired a minority stake in Vivason
Private Equity | Consumer & Retail | Healthcare

Indigo Capital has acquired a minority stake in Vivason

Indigo Capital has acquired a minority stake in Vivason, a leading network of hearing care centers, to support the company’s growth and enable management to increase its ownership stake.

Learn more
UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more